Publications by authors named "Jennifer Mertz"

Claim this Profile
E
Equity in Digital Health: Assessing Access and Utilization of Remote Patient Monitoring, Medical Apps, and Wearables in Underserved Communities.
Omolola Adepoju, Patrick Dang, Holly Nguyen, Jennifer Mertz

Inquiry· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant Cancers.
Patricia J Keller, Elizabeth J Adams, Rentian Wu, Alexandre Côté, Shilpi Arora, Jennifer A Mertz

Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of second-generation EZH2 inhibitors with extended residence times and improved biological activity.
Jacob I Stuckey, Nico R Cantone, Alexandre Côté, Shilpi Arora, Valerie Vivat, Jennifer A Mertz

J Biol Chem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.
Yinshi Huang, Sabikun Nahar, Akifumi Nakagawa, Maite G Fernandez-Barrena, Jennifer A Mertz

Clin Cancer Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma.
Andrew R Conery, Richard C Centore, Adrianne Neiss, Patricia J Keller, Shivangi Joshi, Jennifer A Mertz

Elife· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition.
Srimoyee Ghosh, Alexander Taylor, Melissa Chin, Hon-Ren Huang, Andrew R Conery, Jennifer A Mertz

J Biol Chem· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response.
Andrew R Conery, Richard C Centore, Kerry L Spillane, Nicole E Follmer, Archana Bommi-Reddy, Jennifer A Mertz

Cancer Res· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials.
Brian K Albrecht, Victor S Gehling, Michael C Hewitt, Rishi G Vaswani, Alexandre Côté, Jennifer A Mertz

J Med Chem· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Benzotriazolo[4,3-d][1,4]diazepines as Orally Active Inhibitors of BET Bromodomains.
Alexander M Taylor, Rishi G Vaswani, Victor S Gehling, Michael C Hewitt, Yves Leblanc, Jennifer A Mertz

ACS Med Chem Lett· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma.
Andrew R Conery, Richard C Centore, Adrianne Neiss, Patricia J Keller, Shivangi Joshi, Jennifer A Mertz

Elife· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tessier No. 3 and No. 4 clefts: Sequential treatment in infancy by pre-surgical orthopedic skeletal contraction, comprehensive reconstruction, and novel surgical lengthening of the ala base-canthal distance.
John L Spolyar, Mark Hnatiuk, Kenneth W Shaheen, Jennifer K Mertz, Lawrence F Handler

J Craniomaxillofac Surg· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of methyl isoxazoleazepines as inhibitors of BET.
Michael C Hewitt, Yves Leblanc, Victor S Gehling, Rishi G Vaswani, Alexandre Côté, Jennifer A Mertz

Bioorg Med Chem Lett· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.
Victor S Gehling, Michael C Hewitt, Rishi G Vaswani, Yves Leblanc, Alexandre Côté, Jennifer A Mertz

ACS Med Chem Lett· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting MYC dependence in cancer by inhibiting BET bromodomains.
Jennifer A Mertz, Andrew R Conery, Barbara M Bryant, Peter Sandy, Srividya Balasubramanian

Proc Natl Acad Sci U S A· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retroviral Rem protein requires processing by signal peptidase and retrotranslocation for nuclear function.
Hyewon Byun, Nimita Halani, Jennifer A Mertz, Almas F Ali, Mary M Lozano

Proc Natl Acad Sci U S A· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping of the functional boundaries and secondary structure of the mouse mammary tumor virus Rem-responsive element.
Jennifer A Mertz, Amanda B Chadee, Hyewon Byun, Rick Russell, Jaquelin P Dudley

J Biol Chem· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rev and Rex proteins of human complex retroviruses function with the MMTV Rem-responsive element.
Jennifer A Mertz, Mary M Lozano, Jaquelin P Dudley

Retrovirology· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALY is a common coactivator of RUNX1 and c-Myb on the type B leukemogenic virus enhancer.
Jennifer A Mertz, Ryuji Kobayashi, Jaquelin P Dudley

J Virol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mouse mammary tumor virus encodes a self-regulatory RNA export protein and is a complex retrovirus.
Jennifer A Mertz, Melissa S Simper, Mary M Lozano, Shelley M Payne, Jaquelin P Dudley

J Virol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection for c-myc integration sites in polyclonal T-cell lymphomas.
Dana R Broussard, Jennifer A Mertz, M Lozano, Jaquelin P Dudley

J Virol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis